Join to View Full Profile
505 Parnassus Ave# M1087San Francisco, CA 94143
Fax+1 415-476-5712
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Christopher Ryerson, MD is a pulmonologist in San Francisco, California.
Certifications & Licensure
American Board of Anesthesiology Anesthesiology
Clinical Trials
- The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease Start of enrollment: 2010 Feb 01
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Publications & Presentations
PubMed
- How opaque is ground glass on chest imaging?Na'ama Avitzur, Daniel-Costin Marinescu, Christopher J Ryerson
Thorax. 2025-04-23 - The Use of CT Densitometry for the Assessment of Emphysema in Clinical Trials: A Position Paper from the Fleischner Society.Raúl San José Estépar, R Graham Barr, Sean B Fain, Philippe A Grenier, Eric A Hoffman
American Journal of Respiratory and Critical Care Medicine. 2025-03-24 - 1 citationsEffects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study.Yet Hong Khor, Andreas Palm, Alyson W Wong, Sabina A Guler, Filip Björklund
Thorax. 2025-03-20
Press Mentions
Low BMI, Weight Loss Predict Mortality Risk in ILDJanuary 4th, 2022
What the Health?! Can Feather Duvets Really Cause Lung Disease?November 29th, 2019
Transbronchial Lung Cryobiopsy a Valid Diagnostic Option in Interstitial Lung DiseaseOctober 7th, 2019- Join now to see all
